These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 14724566)

  • 1. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
    Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P; Schmidt M; Hu X; Wolff L
    Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16(INK4a) and p53 deficiency cooperate in tumorigenesis.
    Sharpless NE; Alson S; Chan S; Silver DP; Castrillon DH; DePinho RA
    Cancer Res; 2002 May; 62(10):2761-5. PubMed ID: 12019151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis.
    Sharpless NE; Bardeesy N; Lee KH; Carrasco D; Castrillon DH; Aguirre AJ; Wu EA; Horner JW; DePinho RA
    Nature; 2001 Sep; 413(6851):86-91. PubMed ID: 11544531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
    Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
    Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC
    Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.
    Bardeesy N; Aguirre AJ; Chu GC; Cheng KH; Lopez LV; Hezel AF; Feng B; Brennan C; Weissleder R; Mahmood U; Hanahan D; Redston MS; Chin L; Depinho RA
    Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5947-52. PubMed ID: 16585505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.
    Krimpenfort P; Quon KC; Mooi WJ; Loonstra A; Berns A
    Nature; 2001 Sep; 413(6851):83-6. PubMed ID: 11544530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus.
    Gilley J; Fried M
    Oncogene; 2001 Nov; 20(50):7447-52. PubMed ID: 11704876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
    Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
    Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
    Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
    Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic dissection of melanoma pathways in the mouse.
    Yang FC; Merlino G; Chin L
    Semin Cancer Biol; 2001 Jun; 11(3):261-8. PubMed ID: 11407950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
    Wang Y; Zhang Z; Kastens E; Lubet RA; You M
    Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation.
    Deneen B; Denny CT
    Oncogene; 2001 Oct; 20(46):6731-41. PubMed ID: 11709708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of INK4a locus in normal eye development and cataract genesis.
    Cheong C; Sung YH; Lee J; Choi YS; Song J; Kee C; Lee HW
    Mech Ageing Dev; 2006 Jul; 127(7):633-8. PubMed ID: 16620915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging.
    Matheu A; Pantoja C; Efeyan A; Criado LM; Martín-Caballero J; Flores JM; Klatt P; Serrano M
    Genes Dev; 2004 Nov; 18(22):2736-46. PubMed ID: 15520276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo.
    Sharpless NE; Kannan K; Xu J; Bosenberg MW; Chin L
    Oncogene; 2003 Aug; 22(32):5055-9. PubMed ID: 12902988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The INK4a/ARF locus and melanoma.
    Sharpless E; Chin L
    Oncogene; 2003 May; 22(20):3092-8. PubMed ID: 12789286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.